MD

MKT CAP:$2B

Pediatrix Medical Group, Inc.

Market Cap

$2B

Healthcare·Medical - Care Facilities·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$22.76+$1.47 (+6.90%)

Apr 23, 2026

Company Details

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, su...

CEO

Kasandra H. Rossi

IPO Date

Sep 20, 1995

Website

www.mednax.com

Key Metrics TTM

Revenue

$1.9B

-4.9% YoY

Net Income

$165M

EPS (Diluted)

$1.93

Free Cash Flow

$253M

Revenue / Share

$22.67

Gross Margin

25.5%

Operating Margin

11.2%

Net Margin

8.6%

FCF Margin

13.2%

P/S

1.0x

P/E

11.6x

Earnings Reports

Q1 2026

May 5, 2026

PENDING

Q4 2025

Feb 19, 2026

$494M-1.7%EPS $0.40

Q3 2025

Nov 3, 2025

$493M-3.6%EPS $0.84

Q2 2025

Aug 5, 2025

$469M-7.0%EPS $0.45

Q1 2025

May 6, 2025

$458M-7.4%EPS $0.24

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 18	$916M	$263M	$129M
Q3 18	$897M	$241M	$109M
Q4 18	$933M	$246M	$104M
Q3 19	$889M	$231M	-$1.4B
Q1 23	$491M	$98M	$30M
Q2 23	$501M	$115M	$48M
Q3 23	$507M	$107M	$40M
Q4 23	$496M	$101M	-$111M
Q1 24	$495M	$95M	$16M
Q2 24	$504M	$114M	-$158M
Q3 24	$511M	$117M	$34M
Q4 24	$502M	$129M	$39M
Q1 25	$458M	$103M	$32M
Q2 25	$469M	$125M	$60M
Q3 25	$493M	$140M	$68M
Q4 25	$494M	$120M	$55M

Valuation

Quarter	P/S	P/E
Q2 18	0.5x	5.6x
Q3 18	0.5x	5.6x
Q4 18	0.5x	7.1x
Q3 19	0.5x	—
Q1 23	0.6x	—
Q2 23	0.7x	—
Q3 23	0.8x	—
Q4 23	1.0x	—
Q1 24	1.0x	—
Q2 24	1.0x	—
Q3 24	1.0x	—
Q4 24	1.0x	—
Q1 25	1.0x	—
Q2 25	1.0x	17.4x
Q3 25	1.0x	11.8x
Q4 25	1.0x	11.6x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 18	$135M	$121M
Q3 18	$141M	$129M
Q4 18	$128M	$117M
Q3 19	$156M	$148M
Q1 23	-$101M	-$108M
Q2 23	$89M	$81M
Q3 23	$80M	$71M
Q4 23	$69M	$60M
Q1 24	-$125M	-$131M
Q2 24	$107M	$100M
Q3 24	$92M	$86M
Q4 24	$133M	$130M
Q1 25	-$117M	-$121M
Q2 25	$137M	$133M
Q3 25	$137M	$132M
Q4 25	$114M	$109M

Capital Expenditures

Quarter	CapEx
Q2 18	$14M
Q3 18	$12M
Q4 18	$11M
Q3 19	$9M
Q1 23	$7M
Q2 23	$8M
Q3 23	$9M
Q4 23	$9M
Q1 24	$5M
Q2 24	$7M
Q3 24	$6M
Q4 24	$3M
Q1 25	$3M
Q2 25	$5M
Q3 25	$5M
Q4 25	$5M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 18	+8.7%	+9.2%
Q3 18	+3.2%	+6.1%
Q4 18	+2.4%	+5.6%
Q3 19	-1.5%	+182.0%
Q1 23	-46.4%	-41.4%
Q2 23	-44.2%	-42.6%
Q3 23	-45.7%	-43.8%
Q4 23	-44.1%	-73.0%
Q1 24	+0.8%	+4.0%
Q2 24	+0.7%	+46.4%
Q3 24	+0.9%	+2.4%
Q4 24	+1.2%	-23.8%
Q1 25	-7.4%	-11.0%
Q2 25	-7.0%	-38.2%
Q3 25	-3.6%	-11.0%
Q4 25	-1.7%	-5.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 18	$11M	1.1%
Q3 18	$9M	1.0%
Q4 18	$9M	1.0%
Q3 19	$8M	0.9%
Q1 23	$3M	0.6%
Q2 23	$3M	0.6%
Q3 23	$3M	0.6%
Q4 23	$3M	0.6%
Q1 24	$3M	0.6%
Q2 24	$2M	0.4%
Q3 24	$4M	0.8%
Q4 24	$3M	0.5%
Q1 25	$4M	0.8%
Q2 25	$4M	0.8%
Q3 25	$3M	0.7%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	G&A
Q2 18	$108M
Q3 18	$103M
Q4 18	$113M
Q3 19	$102M
Q1 23	$59M
Q2 23	$58M
Q3 23	$57M
Q4 23	$53M
Q1 24	$60M
Q2 24	$57M
Q3 24	$58M
Q4 24	$64M
Q1 25	$59M
Q2 25	$56M
Q3 25	$61M
Q4 25	$66M

Revenue Segments

Quarter	Health Care	Health Care, Patient Service	Hospitals Contracts	Management Service	Product and Service, Other
Q2 18	$916M	—	—	—	—
Q3 18	$897M	—	—	—	—
Q4 18	—	$790M	$90M	$53M	—
Q3 19	—	$785M	$98M	—	$6M
Q1 23	—	$423M	$66M	—	$2M
Q2 23	—	$430M	$70M	—	$609.0K
Q3 23	—	$437M	$69M	—	$579.0K
Q4 23	—	$425M	$71M	—	—
Q1 24	—	$422M	$72M	—	$1M
Q2 24	—	$433M	$71M	—	$536.0K
Q3 24	—	$439M	$72M	—	$70.0K
Q4 24	—	$430M	$72M	—	$558.0K
Q1 25	—	$389M	$65M	—	$4M
Q2 25	—	$397M	$68M	—	$3M
Q3 25	—	$422M	$68M	—	$3M
Q4 25	—	$422M	$70M	—	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$7M	$90M	$97M
Q2 22	$14M	$93M	$107M
Q3 22	$9M	$91M	$100M
Q4 22	$10M	$93M	$103M
Q1 23	$6M	$97M	$103M
Q2 23	$6M	$98M	$104M
Q3 23	$21M	$104M	$125M
Q4 23	$73M	$104M	$178M
Q1 24	$8M	$107M	$115M
Q2 24	$19M	$114M	$133M
Q3 24	$104M	$117M	$220M
Q4 24	$230M	$119M	$349M
Q1 25	$99M	$120M	$219M
Q2 25	$225M	$124M	$348M
Q3 25	$340M	$123M	$463M
Q4 25	$375M	$124M	$500M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 18	94M	+0.0%	+0.8%
Q3 18	91M	-2.3%	-1.6%
Q4 18	88M	-3.4%	-5.8%
Q3 19	83M	-6.1%	-11.4%
Q1 23	82M	-0.7%	-12.0%
Q2 23	83M	+0.4%	-9.5%
Q3 23	83M	+0.3%	-6.0%
Q4 23	84M	+1.3%	+1.4%
Q1 24	83M	-0.9%	+1.2%
Q2 24	83M	+0.1%	+0.8%
Q3 24	85M	+1.4%	+1.9%
Q4 24	86M	+1.6%	+2.2%
Q1 25	86M	-0.1%	+3.0%
Q2 25	87M	+1.2%	+4.2%
Q3 25	86M	-1.4%	+1.3%
Q4 25	84M	-1.4%	-1.7%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 18	$119.3K	8K
Q3 18	$116.8K	8K
Q4 18	$122.3K	8K
Q3 19	$116.5K	8K
Q1 23	$175.4K	3K
Q2 23	$178.8K	3K
Q3 23	$180.9K	3K
Q4 23	$171.2K	3K
Q1 24	$170.7K	3K
Q2 24	$173.9K	3K
Q3 24	$176.3K	3K
Q4 24	$233.7K	2K
Q1 25	$213.2K	2K
Q2 25	$218.1K	2K
Q3 25	$229.2K	2K
Q4 25	$1M	400

Revenue / Employee